Ivan Kairatov is a leading biopharma expert with a deep understanding of how generative artificial intelligence is reshaping the landscape of drug development. With extensive experience in research and development, he has been at the forefront of integrating computational biology with traditional
Ivan Kairatov is a leading biopharma expert with a deep specialty in integrating cutting-edge technology into clinical research and development. With extensive experience in navigating the complexities of medical innovation, he has focused his career on how artificial intelligence can bridge the
The intricate architecture of the human gut serves as a delicate frontier where trillions of microbes meet the body’s immune system in a constant, silent negotiation for balance. For millions of people living with ulcerative colitis, this internal peace treaty has collapsed, replaced by a
Every thirty seconds, a clinician somewhere in the world stares at a cryptic electrocardiogram, desperately searching for the subtle clues of a hidden heart attack that could cost a patient their life. This high-stakes environment is where the traditional diagnostic framework often falters,
The current landscape of medical technology is undergoing a seismic shift as digital twins evolve from conceptual experimental models into indispensable assets for clinical decision-making and hospital administration. As of 2026, the global market for these virtual replicas has already surpassed
The medical community has long treated the thymus as a relic of childhood development, a small gland in the chest that supposedly retires once we hit puberty. However, recent groundbreaking research is turning this dogma on its head, revealing that the thymus remains a critical engine for adult
